Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Parallel Session 3408

Early/Prodromal Parkinson's Disease

Tuesday, October 6, 2026
14:30 - 16:00 | Conference Room North 202, Level 2

This session will focus upon the early stages of Parkinson’s disease, particularly looking at under-recognized non motor aspects of disease and how prodromal stages can vary between individuals. A summary of ongoing and future trials for Parkinson’s disease secondary prevention will be provided.

Chairs:

Yu Jin Jung, Korea
Ron Postuma, Canada

Presenters:

Subtypes and Evolution Patterns in Prodromal Parkinson's Disease
Per Borghammer, Denmark

Cognitive and Autonomic Dysfunction in Prodromal Parkinson's Disease
Steve Joza, Canada

The future of Prodromal PD – Cohorts, Trials and Definition Changes
Margherita Fabbri, France

CSPC Liaison(s):

Ron Postuma, Canada

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Trace individual differences in how early Parkinson's disease evolves and implications for understanding disease pathophysiology
  2. Outline the implications of mild cognitive decline and autonomic failure as early Parkinson's disease markers
  3. Envision the future of prodromal Parkinson's disease, including ongoing cohorts, current/future trials, and challenges to definitions created by biomarker advances

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Intermediate / Experienced